Back to results
US 2020/0369703 A1Published application
Modified oligonucleotides and compound that can be used for synthesizing same
AssigneeGuangzhou Ribobio Co., Ltd.
InventorsBiliang ZHANG, Wei WANG
Life of this patent
Estimating the term…
Abstract
The present disclosure falls within the field of biomedical technology, and in particular relates to modified oligonucleatides and a compound that can be used for synthesizing same and a method for modifying oligonucleotides. The present disclosure also relates to the use of the modified oligonucleotides for preventing and/or treating diseases associated with the liver in a subject.
Claims21
1-31. (canceled)
A compound having a general formula of Ax-linker-R, wherein Ax is a ligand, linker is a linker arm, and R is selected from R1, R2, R3 or R4,
- wherein Ax is a ligand of a human asialoglycoprotein receptor (ASGPR),
- R1 is
- wherein, Z is a protecting group for hydroxy, preferably 4, 4-dimethoxytriphenylalkyl (DMTr) or 4-methoxytriphenylchloromethyl (MMT);
- R2 is
- and wherein, m1, and m2 are each independently selected from integers between 1 and 10, and Z is a protecting group for hydroxy, preferably 4, 4-dimethoxytriphenylmethyl (DMTr) or 4-methoxytriphenylchloromethyl (MMT);
- R3 is
- R4 is
4 more elements
Dependencies are inferred from the claim text.